The obstruction was based on post-bronchodilator FEV1/FVC < lower limit of normal (LLN) and <0.70 (fixed ratio). A total of 2,352 subjects (54% male, post-bronchodilator FEV1 76.5% predicted) were ...

Combined treatment with bronchodilator drugs and steroids resulted in a mean increase in vital capacity and first-second volume of almost 50 per cent of the pretreatment value.

Tozorakimab, an anti-IL-33 antibody, improves lung function and may reduce exacerbations in high-risk COPD patients, early ...

PEF failed to consistently reflect FEV1 improvements after bronchodilation, indicating that handheld spirometry may better ...

Bronchodilator responsiveness was defined as an increase in either FEV 1 or FVC by at least 12% and at least 200 ml after bronchodilator use, in accordance with the American Thoracic Society and ...

Notably, the likelihood for bronchodilator responsiveness per the 2005 definition significantly went down with testing in autumn vs. winter (aOR = 0.67; 95% CI, 0.48-0.92), according to the study.

Little Evidence Behind Bronchodilator Therapy For Cystic Fibrosis. ScienceDaily . Retrieved May 15, 2025 from www.sciencedaily.com / releases / 2005 / 10 / 051026085739.htm ...

NEW ORLEANS — Use of spirometry with bronchodilator testing can help reduce overdiagnosis of COPD as well as help differentiate COPD from asthma and asthma-COPD overlap syndrome, researchers ...

HealthDay News — Patients are more likely to have positive bronchodilator responsiveness in the morning and in winter months, according to a study published online March 11 in Thorax.. Ben Knox ...

A new study from Brigham and Women's Hospital (BWH) reveals several new gene variants that are associated with how people living with chronic obstructive pulmonary disease (COPD) respond to ...